Results 41 to 50 of about 41,379 (243)
Legal gems: Supply of S3 naloxone
, 2017 In February 2016, naloxone 400 mcg/mL was rescheduled for supply as a Schedule 3 (S3; Pharmacist Only) medication for the treatment of opioid overdose. For all other purposes, naloxone remains a Schedule 4 (S4; Prescription Only) medication.
Dickfos, Steven T +2 more
core +1 more source
PM&R, EarlyView.Abstract Background and Objective Previous work from this dataset found 45% prescribing frequency of any medications (35.1%, 33.5%, and 56.8% at institutions 1, 2, and 3 respectively), without significant difference between in‐person and telemedicine.
Matthew Chen +7 more
wiley +1 more source
Naloxone induced pulmonary edema
, 2021 Naloxone-induced noncardiogenic pulmonary edema is a rare but reported entity that can occur following naloxone use in the reversal of opioid overdose.
Ramez Alyacoub +4 more
core +1 more source
Nature CommunicationsSevere opioid-induced respiratory depression (OIRD) can be treated with intranasal (IN) or intramuscular (IM) naloxone. It is relevant to compare their efficacy and determine the optimal strategy to restore breathing following OIRD.
Maarten A. van Lemmen +5 more
doaj +1 more source
Recent progress on the development of hydrogel‐based microneedles for transdermal drug delivery
VIEW, EarlyView.This study provides a comprehensive and up‐to‐date analysis of recent progress in HMN technology, covering fundamental transdermal delivery mechanisms and design principles, biomaterials used in HMN fabrication, drug loading and release strategies, and emerging therapeutic applications.
Mohammad Muhtasim Ittisaf +5 more
wiley +1 more source
Rapid widespread distribution of intranasal naloxone for overdose prevention
, 2017 Background: In order to have a substantial impact on overdose prevention, the expansion and scalingup of overdose prevention with naloxone distribution (OPEND) programs are needed.
Lobmaier, Philipp Paul +2 more
core +1 more source
Preventing opioid overdose with peer-administered naloxone: findings from a rural state
Harm Reduction Journal, 2020 Background In response to the opioid epidemic, naloxone distribution programs aim to prevent overdose death by making naloxone available and training people to use it.
Bridget L. Hanson +3 more
doaj +1 more source
Drugs in Context, 2021 Background: Older adults (≥65 years) have seen significant increases in opioid overdose deaths. Diversion of older adults’ opioid medication is also a contributor to opioid misuse.
Brianna M McQuade +4 more
doaj +1 more source
Broadening the View: Substance P and Its Metabolism in Pruritus‐Related Diseases
The Journal of Dermatology, EarlyView.ABSTRACT Chronic pruritus is a debilitating symptom accompanying numerous inflammatory skin diseases and remains a major therapeutic challenge. Neurogenic inflammation plays a central role in its pathogenesis, with the tachykinin substance P acting as a key mediator at the interface of the nervous system, immune cells, and cutaneous tissues.
Thomas Walter, Bjoern B. Burckhardt
wiley +1 more source
Use of nebulized naloxone to reverse methadone overdose – A case report and review of literature
Journal of Community Hospital Internal Medicine Perspectives, 2019 Opioid use is a frequent cause of morbidity and mortality in the USA. We report a case of methadone overdose reversed with naloxone nebulization. Peripheral IV access can be difficult to obtain in patients with a history of IV drug abuse making needless ...
Muhammad Sameed, Heidi Teague
doaj +1 more source